Total submissions: 11
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Genetic Services Laboratory, |
RCV000116782 | SCV000150764 | likely benign | not specified | 2013-08-27 | criteria provided, single submitter | clinical testing | |
Gene |
RCV000116782 | SCV000167809 | benign | not specified | 2013-12-04 | criteria provided, single submitter | clinical testing | This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. |
Eurofins Ntd Llc |
RCV000725230 | SCV000335177 | uncertain significance | not provided | 2015-09-28 | criteria provided, single submitter | clinical testing | |
Illumina Laboratory Services, |
RCV000338723 | SCV000467295 | uncertain significance | Cortical dysplasia-focal epilepsy syndrome | 2016-06-14 | criteria provided, single submitter | clinical testing | |
Illumina Laboratory Services, |
RCV000399457 | SCV000467296 | uncertain significance | Pitt-Hopkins-like syndrome | 2016-06-14 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV000338723 | SCV000563247 | likely benign | Cortical dysplasia-focal epilepsy syndrome | 2025-01-25 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002316301 | SCV000850722 | likely benign | Inborn genetic diseases | 2016-04-22 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Ce |
RCV000725230 | SCV004161282 | likely benign | not provided | 2023-08-01 | criteria provided, single submitter | clinical testing | CNTNAP2: BP4, BP7 |
Genome Diagnostics Laboratory, |
RCV000725230 | SCV001932660 | likely benign | not provided | no assertion criteria provided | clinical testing | ||
Clinical Genetics DNA and cytogenetics Diagnostics Lab, |
RCV000725230 | SCV001963732 | likely benign | not provided | no assertion criteria provided | clinical testing | ||
Prevention |
RCV003925133 | SCV004738908 | likely benign | CNTNAP2-related disorder | 2020-01-28 | no assertion criteria provided | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |